Empagliflozin Sheds Liver Fat in People With and Without T2D : vimarsana.com

Empagliflozin reduced liver fat content in patients with obesity and patients with type 2 diabetes.

Related Keywords

San Antonio , Texas , United States , University Of Texas , Siham Abdelgani , Division Of Diabetes , University Of Texas Health Science Center , Texas Health Science Center , Obesity , Bese , Liver , Liver Disease , Hepatic Impairment , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Ype 2 Diabetes , Ype 2 Dm , T2dm , 2d , Grant ,